CHRISTOPHER K. Mirabelli

Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions.

S. Crooke, C. Mirabelli, R. M. Snyder, 1986, Biochemical pharmacology.

Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.

M. Mattern, C. Mirabelli, N. Hanna, 1990, Cancer research.

Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.

A. Badger, C. Mirabelli, M. Dimartino, 1985, Immunopharmacology.

The cellular pharmacology of auranofin.

S. Crooke, C. Mirabelli, R. M. Snyder, 1987, Seminars in arthritis and rheumatism.

Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds.

S. Crooke, J. Bartus, C. Mirabelli, 1987, Journal of medicinal chemistry.